Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Clinical trial NCT01165177 · COMPLETED
Trial details
- NCT number
- NCT01165177
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-02
- Primary completion
- 2014-05-09
- Enrollment
- 16165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.